Amid a federal probe into its lending practices, Arbor Realty Trust now faces two more suits by investors alleging the REIT ...

Arbor Realty Trust ABR shares plunged 16% over the past six months, underperforming the industry’s growth of 0.5% and the S&P ...

The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients ...

The gene therapy world is in turmoil, but Arbor, armed with more than a billion dollars in partnerships and raises, is going forward.

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.

Cibc World Markets Corp purchased a new stake in Arbor Realty Trust, Inc. (NYSE:ABR – Free Report) in the fourth quarter, ...